528 related articles for article (PubMed ID: 15563519)
21. Antibiotic susceptibility of streptococci isolated from blood from neutropenic patients.
Piérard D; de Meyer A; Lauwers S
Pathol Biol (Paris); 1994 May; 42(5):471-4. PubMed ID: 7824316
[TBL] [Abstract][Full Text] [Related]
22. Moxifloxacin and biofilm production by coagulase-negative staphylococci.
Pérez-Giraldo C; Gonzalez-Velasco C; Sánchez-Silos RM; Hurtado C; Blanco MT; Gómez-García AC
Chemotherapy; 2004 Jun; 50(2):101-4. PubMed ID: 15211086
[TBL] [Abstract][Full Text] [Related]
23. Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis.
Roveta S; Schito AM; Marchese A; Schito GC
Int J Antimicrob Agents; 2007 Nov; 30(5):415-21. PubMed ID: 17768034
[TBL] [Abstract][Full Text] [Related]
24. [Phenotypes and genetic mechanisms of resistance to macrolides and lincosamides in viridans group streptococci].
Artiles Campelo F; Horcajada Herrera I; Alamo Antúnez I; Cãnas Pedrosa A; Lafarga Capuz B
Rev Esp Quimioter; 2007 Sep; 20(3):317-22. PubMed ID: 18080028
[TBL] [Abstract][Full Text] [Related]
25. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
[TBL] [Abstract][Full Text] [Related]
26. In vitro susceptibility of viridans group streptococci isolated from blood in southwest Finland in 1993-2004.
Lindgren M; Jalava J; Rantakokko-Jalava K; Meurman O
Scand J Infect Dis; 2007; 39(6-7):508-13. PubMed ID: 17577811
[TBL] [Abstract][Full Text] [Related]
27. In vitro effect of subinhibitory concentrations of antibiotics on biofilm formation by clinical strains of Salmonella enterica serovar Typhimurium isolated in Slovakia.
Majtán J; Majtánová L; Xu M; Majtán V
J Appl Microbiol; 2008 May; 104(5):1294-301. PubMed ID: 18028358
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis.
Ha KR; Psaltis AJ; Butcher AR; Wormald PJ; Tan LW
Laryngoscope; 2008 Mar; 118(3):535-40. PubMed ID: 18090864
[TBL] [Abstract][Full Text] [Related]
29. Effects of alcohols, povidone-iodine and hydrogen peroxide on biofilms of Staphylococcus epidermidis.
Presterl E; Suchomel M; Eder M; Reichmann S; Lassnigg A; Graninger W; Rotter M
J Antimicrob Chemother; 2007 Aug; 60(2):417-20. PubMed ID: 17586808
[TBL] [Abstract][Full Text] [Related]
30. [Clinical significance of bacteremia caused by streptococci of the viridans group].
Ruiz MP; Soriano F
Enferm Infecc Microbiol Clin; 1994 Nov; 12(9):426-32. PubMed ID: 7811768
[TBL] [Abstract][Full Text] [Related]
31. Successful ceftriaxone therapy of endocarditis due to penicillin non-susceptible viridans streptococci.
Shelburne SA; Greenberg SB; Aslam S; Tweardy DJ
J Infect; 2007 Feb; 54(2):e99-101. PubMed ID: 16824611
[TBL] [Abstract][Full Text] [Related]
32. Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis.
Streit JM; Steenbergen JN; Thorne GM; Alder J; Jones RN
J Antimicrob Chemother; 2005 Apr; 55(4):574-8. PubMed ID: 15722390
[TBL] [Abstract][Full Text] [Related]
33. "Streptococcus milleri" endocarditis caused by Streptococcus anginosus.
Woo PC; Tse H; Chan KM; Lau SK; Fung AM; Yip KT; Tam DM; Ng KH; Que TL; Yuen KY
Diagn Microbiol Infect Dis; 2004 Feb; 48(2):81-8. PubMed ID: 14972375
[TBL] [Abstract][Full Text] [Related]
34. Viridans group streptococci bloodstream infections in neutropenic adult patients with hematologic malignancy: Single center experience.
Radocha J; Paterová P; Zavřelová A; Víšek B; Gabalec F; Žemličková H; Žák P
Folia Microbiol (Praha); 2018 Mar; 63(2):141-146. PubMed ID: 28776170
[TBL] [Abstract][Full Text] [Related]
35. In vitro inferiority of ceftazidime compared with other beta-lactams for viridans group Streptococcus bacteremia in pediatric oncology patients: implications for antibiotic choices.
Paulus S; Dobson S; Rassekh S; Blondel-Hill E
J Pediatr Hematol Oncol; 2009 Apr; 31(4):267-9. PubMed ID: 19346878
[TBL] [Abstract][Full Text] [Related]
36. A retrospective analysis of biofilm antibiotic susceptibility testing: a better predictor of clinical response in cystic fibrosis exacerbations.
Keays T; Ferris W; Vandemheen KL; Chan F; Yeung SW; Mah TF; Ramotar K; Saginur R; Aaron SD
J Cyst Fibros; 2009 Mar; 8(2):122-7. PubMed ID: 19064337
[TBL] [Abstract][Full Text] [Related]
37. Differences in biofilm development and antibiotic susceptibility among clinical Ureaplasma urealyticum and Ureaplasma parvum isolates.
García-Castillo M; Morosini MI; Gálvez M; Baquero F; del Campo R; Meseguer MA
J Antimicrob Chemother; 2008 Nov; 62(5):1027-30. PubMed ID: 18753188
[TBL] [Abstract][Full Text] [Related]
38. Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature.
Zinkernagel AS; Zinkernagel MS; Elzi MV; Genoni M; Gubler J; Zbinden R; Mueller NJ
Infection; 2008 Aug; 36(4):314-21. PubMed ID: 18648747
[TBL] [Abstract][Full Text] [Related]
39. Activity of dalbavancin against staphylococci and streptococci, assessed by BSAC and NCCLS agar dilution methods.
Mushtaq S; Warner M; Johnson AP; Livermore DM
J Antimicrob Chemother; 2004 Sep; 54(3):617-20. PubMed ID: 15321983
[TBL] [Abstract][Full Text] [Related]
40. Characterization of high-level daptomycin resistance in Viridans group Streptococci developed upon in vitro exposure to daptomycin.
Akins RL; Katz BD; Monahan C; Alexander D
Antimicrob Agents Chemother; 2015 Apr; 59(4):2102-12. PubMed ID: 25624330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
